Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 23c; updates guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of $1.26, $0.23 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.85 billion versus the consensus estimate of $2.66 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2026 revenue of $10.79-11.04 billion, versus the consensus of $10.725 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Iambic Therapeutics (IAM) files for proposed IPO
• BD names Arthur Hu as chief information and digital officer
• Hycroft Mining updates development plans at Nevada gold and silver mine